Phibro Animal Health PAHC Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Animal Health | $1.16B+2.9% | $1.12B+5.7% | $1.06B+10.5% | $962.8M+11.7% | $861.83M+9.8% | |
| Mineral Nutrition | $269.51M+2.5% | $262.86M+2.2% | $257.17M+1.6% | $253.24M+0.8% | $251.15M+1.0% | |
| Performance Products | $73.4M-4.9% | $77.18M-2.0% | $78.78M-1.7% | $80.18M+3.2% | $77.7M+6.9% | |
| Selling General And Administrative Expense by Business | ||||||
| Mineral Nutrition | $7.64M+0.2% | $7.62M+2.6% | $7.43M-2.8% | $7.64M+2.8% | $7.43M+2.1% | |
| Performance Products | $8.9M+1.3% | $8.79M+4.0% | $8.45M+0.5% | $8.41M+1.8% | $8.26M+1.4% | |
| Adjusted Earnings Before Interest Taxes Depreciation And Amortization by Business | ||||||
| Mineral Nutrition | $21.64M-2.8% | $22.26M+3.1% | $21.6M+3.7% | $20.84M+1.0% | $20.62M+5.6% | |
| Performance Products | $7.69M-12.7% | $8.8M-10.7% | $9.86M-6.5% | $10.55M-0.3% | $10.58M+10.0% | |
| Cost of Goods Sold by Business | ||||||
| Mineral Nutrition | $242.4M+3.1% | $235.12M+2.1% | $230.26M+1.5% | $226.86M+0.7% | $225.39M+1.8% | |
| Performance Products | $57.76M-4.6% | $60.56M-1.5% | $61.5M-1.4% | $62.37M+6.4% | $58.64M+7.5% | |
| D&A by Business | ||||||
| Mineral Nutrition | $2.17M+1.1% | $2.15M+1.2% | $2.12M+0.9% | $2.1M+1.3% | $2.08M-3.6% | |
| Performance Products | $951K-2.9% | $979K-5.0% | $1.03M-9.4% | $1.14M-12.5% | $1.3M-10.7% | |
| Revenue by Product | ||||||
| Medicated Feed Additives And Others | $809.63M+3.1% | $785.48M+7.1% | $733.71M+13.5% | $646.35M+16.1% | $556.53M+15.2% | |
| Mineral Nutrition | $269.51M+2.5% | $262.86M+2.2% | $257.17M+1.6% | $253.24M+0.8% | $251.15M+1.0% | |
| Nutritional Specialties | $192.57M+1.8% | $189.11M+2.3% | $184.79M+3.1% | $179.29M+2.6% | $174.74M+1.8% | |
| Performance Products | $73.4M-4.9% | $77.18M-2.0% | $78.78M-1.7% | $80.18M+3.2% | $77.7M+6.9% | |
| Vaccines | $154.94M+3.5% | $149.7M+3.1% | $145.23M+5.9% | $137.15M+5.0% | $130.57M+0.4% | |
| Revenue by Geography | ||||||
| Asia Pacific | $114.86M+2.2% | $112.4M+0.2% | $112.19M+15.2% | $97.42M+22.8% | $79.3M+16.3% | |
| EMEA | $191.8M+3.0% | $186.24M+7.0% | $174.05M+8.6% | $160.23M+18.7% | $135.03M+4.4% | |
| Latin America And Canada | $334.52M+1.5% | $329.65M+4.7% | $314.72M+5.4% | $298.65M+4.9% | $284.74M+6.4% | |
| US | $858.86M+2.7% | $836.03M+4.7% | $798.72M+7.9% | $739.92M+7.0% | $691.61M+7.9% | |
| Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization by Geography | ||||||
| BR | $143.93M— | —— | —— | —— | —— | |
| IE | $106.52M— | —— | —— | —— | —— | |
| IL | $306.25M— | —— | —— | —— | —— | |
| US | $949.26M— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Phibro Animal Health break its business down?
- Phibro Animal Health (PAHC) reports revenue by business across 3 parts — Animal Health, Mineral Nutrition and Performance Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Phibro Animal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Phibro Animal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
